Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men.
about
Gastrointestinal hormones regulating appetiteContributions of upper gut hormones and motility to the energy intake-suppressant effects of intraduodenal nutrients in healthy, lean men - a pooled-data analysis.Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.Role and development of GLP-1 receptor agonists in the management of diabetes.Role of cholecystokinin in appetite control and body weight regulation.Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a reviewGastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.Targeting beta-cell cyclic 3'5' adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review.Chronic high-fat feeding increases GIP and GLP-1 secretion without altering body weightGlucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes.Digestive physiology of the pig symposium: secretion of gastrointestinal hormones and eating control.Oral and intestinal sweet and fat tasting: impact of receptor polymorphisms and dietary modulation for metabolic disease.Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Sir David Cuthbertson Medal Lecture. Bariatric surgery as a model to study appetite control.GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects.Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men.Effects of varying combinations of intraduodenal lipid and carbohydrate on antropyloroduodenal motility, hormone release, and appetite in healthy males.Exendin-4 is effective against metabolic disorders induced by intrauterine and postnatal overnutrition in rodents.Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid.Decreased intestinal nutrient response in diet-induced obese rats: role of gut peptides and nutrient receptors.Glucagon-like peptide 1 and pancreatic polypeptide responses to feeding in normal weight and overweight children.High-fat diet effects on gut motility, hormone, and appetite responses to duodenal lipid in healthy men.Effects of small intestinal glucose on glycaemia, insulinaemia and incretin hormone release are load-dependent in obese subjects.Mechanisms responsible for homeostatic appetite control: theoretical advances and practical implications
P2860
Q24669951-53539969-1231-4A95-9F39-699504BF6890Q31128999-48CA1957-DD06-408D-B7FF-3A0BBEAB6A0FQ31149434-59DDF667-AC20-4276-AA26-8B997CF14452Q33635830-97927C3A-3B4B-444C-A080-74B194EE6D48Q34462432-789ADA91-24EE-48CF-BA87-0909E3E91BDBQ34824005-D346F9F8-9A17-4B62-841D-52955B83BFCAQ35827899-1A1B788E-F19C-447A-88DA-E925764027E0Q35962745-87990C7C-971A-47CD-8197-FEA4143CDA62Q36297735-45DB5B77-F40B-4CCC-AE5C-98A27533F10BQ36816194-C7D292BD-9BA8-4C61-A98C-671F7D271374Q38073233-28252393-0380-40CD-A219-96359376775FQ38503042-BEE54D95-E832-48CA-86FD-6D9764808B9BQ39047697-B4126200-37B1-45F1-A861-042E4A1274B1Q44366883-97F61C00-774B-4DEC-896E-3503F553581DQ45066824-377ECB30-5946-4CB6-A51B-3D864611517AQ45253690-A8AC05A7-E8A6-4E51-B08C-899A8C4E00F5Q46124623-1F8F4D26-6F2F-42A4-95BE-943D7D67086AQ46237983-84E72473-4B60-499F-B243-FD9C85ABD873Q46584956-5CD77ACE-EB68-415E-9E06-CD9F0C8B7BDCQ46811140-63F5BB2B-A96A-4988-8B06-5AF8C6D60129Q47174979-C841ACD7-D48A-45CB-B475-C2A825E363C0Q48616153-E9ADC7FD-EA88-4D8C-9B9E-2F7A294E696BQ53553149-736D5766-4154-4EB9-9AA0-C93594F5E90DQ54879432-CEB63879-C736-41AF-B9F0-D5CDE49ED523
P2860
Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Plasma glucagon-like peptide-1 ...... fusions in lean and obese men.
@en
Plasma glucagon-like peptide-1
@nl
type
label
Plasma glucagon-like peptide-1 ...... fusions in lean and obese men.
@en
Plasma glucagon-like peptide-1
@nl
prefLabel
Plasma glucagon-like peptide-1 ...... fusions in lean and obese men.
@en
Plasma glucagon-like peptide-1
@nl
P2093
P1433
P1476
Plasma glucagon-like peptide-1 ...... fusions in lean and obese men.
@en
P2093
Christine Feinle
Ian M Chapman
Judith Wishart
Michael Horowitz
P304
P356
10.1016/S0196-9781(02)00087-6
P577
2002-08-01T00:00:00Z